English
Spanish
Medscape Medical News Headlines
- 24-Hour Urine Testing in Multiple Myeloma: Time to Stop? 8 December, 2024Including 24-hour urine testing in multiple myeloma response assessments is largely unnecessary, a new phase 3 trial suggests. Medscape Medical News
- LBCL: Bispecific Antibodies Fare Less Well in Real-World Analysis 7 December, 2024In the real world, treating relapsed/refractory large B-cell lymphoma with epcoritamab and glofitamab leads to poorer outcomes than in clinical trials. Medscape Medical News
- Common Herbicide a Player in Neurodegeneration? 6 December, 2024Exposure to glyphosate, the most widely used herbicide, exacerbates neuroinflammation and AD-like pathology in mice, with effect lasting even after a significant pause from exposure. Medscape Medical News
- Infection Is the Third-Leading Cause of Death in T2D 6 December, 2024The contribution of infections to mortality in type 2 diabetes is likely underestimated due to the hierarchical structure of ICD-10 codes. Medscape News UK
- Kids With T1D Doing Better, But Still not Meeting Targets 6 December, 2024Advances in diabetes technology and management have led to improvements in A1c, but still not at recommended levels. Medscape News UK
- Physicians Offer Little Sympathy for Slain Insurance CEO 6 December, 2024The fatal shooting of UnitedHealthcare’s CEO this week sparked a wave of online criticism for the nation’s largest insurer, which physicians say routinely denies care their patients need. Medscape Medical News
- New Cancer Vaccines on the Horizon: Renewed Hope or Hype? 6 December, 2024Cancer vaccine research seems to be having a moment. Are recent advances a leap forward or is it too soon to tell? Medscape Medical News
- Empagliflozin May Slow Diabetic Retinopathy 6 December, 2024Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 diabetes and a history of nonproliferative diabetic retinopathy, a US-based cohort study found. Medscape Medical News
- Meta-analysis Probes Rare Potential Vision Risk of GLP-1s 6 December, 2024A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be detected in patients with type 2 diabetes and/or obesity. Medscape Medical News
- LGBTQ+-Inclusive Language Missing in Acne Assessment 6 December, 2024An analysis of patient-reported outcome measures used for acne revealed gaps in the use of LGBTQ+-inclusive language, highlighting barriers to equitable care and assessment. Medscape Medical News
- Can Dendritic Cells Improve ERBB2 Breast Cancer Outcomes? 6 December, 2024Priming the tumor microenvironment with a higher dose of autologous dendritic cells, combined with anti-ERBB2 antibodies, was safe and effective, found a phase 1 study. Medscape Medical News
- DOACs Not Linked to Increased Intracranial Hemorrhage Risk 6 December, 2024A new meta-analysis found direct oral anticoagulants were less likely than antiplatelet therapy to cause intracranial hemorrhage and reinforced adherence to current guidelines for managing atrial fibrillation. Medscape Medical News
- WHO Prioritizes Endemic Pathogens for Vaccine Development 6 December, 2024By addressing regional needs and focusing resources on priority pathogens, the WHO aims to build a more equitable strategy for vaccine development. Medscape Medical News
- PCSK9 Inhibitors Linked to Lower Skin Cancer Risk in Study 6 December, 2024PCSK9 inhibitors were associated with a lower risk for nonmelanoma skin cancer in older adults with atherosclerotic cardiovascular disease, in a retrospective cohort study. Medscape Medical News
- How PAs Are Meeting Mental Health Care Needs 6 December, 2024Physician associates (PAs) are playing a critical role in expanding access to mental health care in the United States. Medscape Medical News